Global Epigenetic Market Growth (Status and Outlook) 2024-2030

Global Epigenetic Market Growth (Status and Outlook) 2024-2030

According to this study, the global Epigenetic market size will reach US$ 11100 million by 2030.

Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.

The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.

This report presents a comprehensive overview, market shares, and growth opportunities of Epigenetic market by product type, application, key players and key regions and countries.

Segmentation by product type:
Reagents
Kits
Instruments
Enzymes
Services

Segmentation by Application:
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis

Please note: The report will take approximately 2 business days to prepare and deliver.